Genetic help for a blood-thinner balancing act? There's little evidence yet that a genetic test improves the safety of warfarin.
出版信息
Harv Heart Lett. 2007 Dec;18(4):1-2.
PMID:18219801
Abstract
摘要
相似文献
1
Genetic help for a blood-thinner balancing act? There's little evidence yet that a genetic test improves the safety of warfarin.
Harv Heart Lett. 2007 Dec;18(4):1-2.
2
Genetic testing for warfarin dosing? Not yet ready for prime time.
Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141.
3
Pathology consultation on warfarin pharmacogenetic testing.
Am J Clin Pathol. 2011 Jan;135(1):13-9. doi: 10.1309/AJCPAO82OTNPUBLW.
4
Refining the use of warfarin through genetic testing.
Int Angiol. 2008 Aug;27(4):271-3.
5
Warfarin and pharmacogenomic testing: what would Pascal do?
Pharmacotherapy. 2009 Mar;29(3):245-7. doi: 10.1592/phco.29.3.245.
6
Pharmacogenomic testing for warfarin dosing: we are ready now.
Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1483-5. doi: 10.1586/erc.09.117.
7
Using genetic testing to guide warfarin therapy.
Nursing. 2012 May;42(5):63-5. doi: 10.1097/01.NURSE.0000413324.63683.ed.
8
Dynamic pharmacogenetic models in anticoagulation therapy.
Clin Lab Med. 2008 Dec;28(4):539-52. doi: 10.1016/j.cll.2008.10.002.
9
Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.
J Thromb Haemost. 2008 Sep;6(9):1450-2. doi: 10.1111/j.1538-7836.2008.03073.x. Epub 2008 Jul 8.
10
Warfarin anticoagulation in children: is there a role for a personalized approach to dosing?
Pharmacogenomics. 2012 Aug;13(11):1211-4. doi: 10.2217/pgs.12.92.
引用本文的文献
1
Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.
Blood. 2009 Apr 23;113(17):3925-30. doi: 10.1182/blood-2008-09-176859. Epub 2008 Dec 12.
Zotero 插件